Xtx Topco LTD Aerovate Therapeutics, Inc. Transaction History

Xtx Topco LTD

  • $1.72 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 07, 2025
SELL
$2.37 - $2.7 $11,864 - $13,516
-5,006 Reduced 21.08%
18,739 $47,000
Q4 2024

Feb 13, 2025
BUY
$1.99 - $2.79 $47,252 - $66,248
23,745 New
23,745 $62,000
Q2 2024

Aug 12, 2024
BUY
$1.41 - $30.75 $29,811 - $650,147
21,143 New
21,143 $35,000

Others Institutions Holding AVTE

# of Institutions
3
Shares Held
1.63M
Call Options Held
0
Put Options Held
0
View Full List

About Aerovate Therapeutics, Inc.

AVTE Quotes by TradingView
  • Ticker AVTE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,448,100
  • Market Cap $65.5M
  • Description
  • Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...
More about AVTE
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email